Provided by Tiger Trade Technology Pte. Ltd.

MaxCyte Inc

1.01
-0.0350-3.37%
Volume:29.54K
Turnover:29.96K
Market Cap:103.72M
PE:-3.01
High:1.04
Open:1.04
Low:1.00
Close:1.04
52wk High:1.87
52wk Low:0.6434
Shares:103.21M
Float Shares:92.68M
Volume Ratio:1.01
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3338
EPS(LYR):-0.4200
ROE:-20.39%
ROA:-10.64%
PB:0.65
PE(LYR):-2.39

Loading ...

Maxcyte® Announces Multi-platform Technology License Partnership with Genentech® to Advance Cell Therapy Development

THOMSON REUTERS
·
Jul 21

Maxcyte - Genentech to Access Maxcyte Expert Gtx Platform and Technologies for Cell Therapy Workflows

THOMSON REUTERS
·
Jul 21

MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026

GlobeNewswire
·
Jul 16

MaxCyte (MXCT) Receives a Buy from Craig-Hallum

TIPRANKS
·
Jul 04

Craig-Hallum Keeps Their Buy Rating on MaxCyte (MXCT)

TIPRANKS
·
Jun 25

Craig-Hallum Reaffirms Their Buy Rating on MaxCyte (MXCT)

TIPRANKS
·
Jun 18

MaxCyte Shareholders Reelect Directors and Ratify Auditor

TIPRANKS
·
Jun 18

MaxCyte shareholders approve CohnReznick as independent auditor for fiscal 2026

Reuters
·
Jun 18

MaxCyte Regains Nasdaq Compliance After Bid Price Recovery

TIPRANKS
·
Jun 17

MaxCyte regains Nasdaq compliance after shares trade above $1 for 10 days

Reuters
·
Jun 17

Analysts Offer Insights on Healthcare Companies: MaxCyte (MXCT) and Incyte (INCY)

TIPRANKS
·
Jun 11

MaxCyte (MXCT) Earnings Call: Cash-Rich, Growth Delayed

TIPRANKS
·
May 14

MaxCyte (MXCT) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
May 13

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR)

TIPRANKS
·
May 13

Stock Market Today: Dow Jones Futures Fall, S&P 500 Gains As Trump Takes Big Tech Leaders To China—Nvidia, Nextpower, Red Cat In Focus

Benzinga Earnings
·
May 13

Cisco, Alibaba And 3 Stocks To Watch Heading Into Wednesday

Benzinga Earnings
·
May 13

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ramsay Health Care (OtherRMSYF) and MaxCyte (MXCT)

TIPRANKS
·
May 13

MaxCyte backs FY26 revenue view $30M-$32M, consensus $30.83M

TIPRANKS
·
May 13

MaxCyte Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

MaxCyte Q1 FY26 net loss narrows to $4.8 million; revenue drops 7% to $9.7 million

Reuters
·
May 13